✦ LIBER ✦

Characteristics of ductal carcinoma in situ found in BRCA1 and BRCA2 mutation carriers

✍ Scribed by Rachel L. Yang; Holly L. Graves; Paul J. Zhang; Katherine Nathanson; Susan M. Domchek; Brain J. Czerniecki; Rachel R. Kelz

Book ID: 118469243
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 53 KB
Volume: 215
Category: Article
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2012.06.327

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The penetrance of ductal carcinoma in si

The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers

✍ Emanuele Mazzola, Su-Chun Cheng, Giovanni Parmigiani 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 294 KB

Predictive factors for BRCA1/BRCA2 mutat

Predictive factors for BRCA1/BRCA2 mutations in women with ductal carcinoma in situ

✍ Soley Bayraktar; Nisreen Elsayegh; Angelica M. Gutierrez Barrera; Heather Lin; H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 800 KB

Hormone status of in-situ cancer in BRCA

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers

✍ Pinchas Osin; Tim Crook; Trevor Powles; Julian Peto; Barry Gusterson; BA Gusters 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 45 KB

Prophylactic oophorectomy in BRCA1 and B

Prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers

✍ T.R. Rebbeck 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Genetic mutations and characteristics of

Genetic mutations and characteristics of “resistant” BRCA1 and BRCA2 carrier cohort

✍ Latif, N.A.; Rebbeck, T.R. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Pathologic characteristics of breast par

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

✍ Camilo Adem; Carol Reynolds; Cheryl L. Soderberg; Jeffrey M. Slezak; Shannon K. 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## BACKGROUND BRCA1 and BRCA2 alterations are associated with an increased risk of developing breast carcinoma. The authors hypothesized that the progression of breast neoplasia may differ between patients with hereditary disease and patients with nonhereditary disease and that this di